MARKET RADAR
SENSEX     NIFTY      Refresh
Bafna Pharmaceuticals Profit & Loss account, Bafna Pharmaceuticals Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Profit & Loss account - Bafna Pharmaceuticals
Bafna Pharmaceuticals
BSE: 532989|NSE: BAFNAPHARM|ISIN: INE878I01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 21, 12:55
37.50
-0.5 (-1.32%)
VOLUME 8,353
LIVE
NSE
May 21, 12:59
37.80
-0.4 (-1.05%)
VOLUME 2,673
Download Annual Report PDF Format 2011 | 2010
Previous Years »

Profit & Loss account of Bafna Pharmaceuticals

 ------------------- in Rs. Cr. -------------------
Mar '12 Mar '11 Mar '10 Mar '09 Mar '08
12 mths 12 mths 12 mths 12 mths 12 mths
Income
Sales Turnover 122.12 102.06 75.70 46.76 40.32
Excise Duty 1.14 0.66 1.17 0.73 0.75
Net Sales 120.98 101.40 74.53 46.03 39.57
Other Income 3.90 0.52 0.65 1.22 0.04
Stock Adjustments 5.82 2.43 0.82 -2.00 0.77
Total Income 130.70 104.35 76.00 45.25 40.38
Expenditure
Raw Materials 95.60 82.18 59.73 33.48 35.90
Power & Fuel Cost 1.72 1.44 1.68 1.04 0.28
Employee Cost 5.67 3.22 2.49 1.65 0.61
Other Manufacturing Expenses 2.55 2.21 1.29 1.07 0.56
Selling and Admin Expenses 0.00 2.66 1.99 1.17 0.61
Miscellaneous Expenses 5.82 0.56 0.23 0.26 0.18
Preoperative Exp Capitalised 0.00 0.00 0.00 0.00 0.00
Total Expenses 111.36 92.27 67.41 38.67 38.14
Mar '12 Mar '11 Mar '10 Mar '09 Mar '08
12 mths 12 mths 12 mths 12 mths 12 mths
Operating Profit 15.44 11.56 7.94 5.36 2.20
PBDIT 19.34 12.08 8.59 6.58 2.24
Interest 8.13 4.30 2.32 2.07 0.58
PBDT 11.21 7.78 6.27 4.51 1.66
Depreciation 5.84 2.27 1.74 1.37 0.35
Other Written Off 0.00 0.50 0.52 0.52 0.02
Profit Before Tax 5.37 5.01 4.01 2.62 1.29
Extra-ordinary items 0.00 -0.29 -0.04 -0.14 0.00
PBT (Post Extra-ord Items) 5.37 4.72 3.97 2.48 1.29
Tax 3.29 1.39 1.49 1.41 0.10
Reported Net Profit 2.07 3.35 2.48 1.07 1.20
Total Value Addition 15.76 10.09 7.69 5.19 2.24
Preference Dividend 0.00 0.00 0.00 0.00 0.00
Equity Dividend 0.00 0.00 0.00 0.00 0.00
Corporate Dividend Tax 0.00 0.00 0.00 0.00 0.00
Per share data (annualised)
Shares in issue (lakhs) 183.81 174.81 159.81 159.81 95.81
Earning Per Share (Rs) 1.13 1.92 1.55 0.67 1.25
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00
Book Value (Rs) 31.57 29.43 25.66 24.11 12.37
Source : Dion Global Solutions Limited

Results of Bafna Pharma

  • News
  • Results
  • Estimates
  • Analysis

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
Quick Links for bafnapharmaceuticals
Related Searches bafnapharmaceuticals Stock Price, Bafna%20Pharma Stock Quote, Bafna%20Pharma Results , Bafna%20Pharma News .. More »
Follow moneycontrol.com

Facebook Twitter RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News | Markets | IPO | Technicals | Mutual Fund | Commodities | Best Portfolio Manager | Bse Sensex | Bombay Stock Exchange | Share Market Live | Recession 2011 | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | National Stock Exchange | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Property rates in India | Rss Feeds | Budget:2008, 2009, 2010, 2011, 2012 |  Intuit Money Manager | RBI Credit Policy | BSE A Group Companies | BSE B Group Stocks | Union Budget  | Financial Glossary  |  Message Board | Moneybhai | India's Premiere Technology Guide |  History India | Davos  | Phaneesh Murthy | Kerala State Electricity Board | Gold | Coal India | Morgan Stanley | BSE SENSEX | India Cements Limited | Indian rupee | Sagar Hospitals | Apple Inc.
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.